Mostrando 2 resultados de: 2
Filtros aplicados
Origen
scopus(2)
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
ReviewAbstract: inTrodUCTion: The management of non-metastatic castration-resistant prostate cancer (nmCrpC) has undPalabras claves:Apalutamide, Castration, Darolutamide, Enzalutamide, Network meta-analysis, prostatic neoplasmsAutores:Briganti A., Diego M. Carrión, Egawa S., Esperto F., Fiori C., Grossmann N.C., Katayama S., Kimura T., Laukhtina E., Mori K., Mostafaei H., Motlagh R.S., Papalia R., Ploussard G., Pradere B., Quhal F., Rajwa P., Schuettfort V.M., Shariat S.F.Fuentes:scopusEuropean Society of residents in Urology (ESRU) and Minerva Urology Nephrology (MUN) reviews project: Update after 3 years of collaboration
OtherAbstract:Palabras claves:Autores:Diego M. Carrión, Esperto F., Fiori C., Mantica G., Pang K.H., Rivas J.G.Fuentes:scopus